NeuroSense receives South Korean patent for ALS drug PrimeC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- S&P 500, Dow on course for slim gains at open as Iran tensions clash with AI optimism
- Oil retreats from one-month high as traders weigh supply risks
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- S&P Global shares rise on report of possible CapIQ spinoff
NeuroSense Granted South Korean Patent Covering PrimeC Composition for ALS
June 11, 2026 9:01 AM EDTPatent claims cover PrimeC's proprietary formulation, manufacturing process and use in ALSExpands intellectual property protection in one of the world's leading pharmaceutical markets, following recent patent advancements in Japan, Brazil, Australia and the United StatesFurther strengthens global patent portfolio as NeuroSense prepares to initiate Phase 3 development of PrimeC
CAMBRIDGE,... More
